Skip to content

Non-interventional observational study on the use of autologous platelet-rich fibrin membranes in the therapy of antiresorbiva-associated necrosis of the jaw

Non-interventional observational study on the use of autologous platelet-rich fibrin membranes in the therapy of antiresorbiva-associated necrosis of the jaw - APANK

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019938
Enrollment
50
Registered
2020-01-14
Start date
2020-07-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K10.2

Interventions

Group 1: Complete necrosis removal (plastic covering using the M. mylohyoideus / Bichat’s fat body) Group 2: Same procedure as in arm 1, but with an additional layer of the PRF membrane before the ten

Sponsors

Universitätsklinikum Schleswig-Holstein (UKSH)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - Patients undergoing MRONJ in stage 1, 2 or 3 according to the criteria of AAOMS - Previous or current use of bisphosphonates or RANK-L inhibitors subcutaneously or intravenously in malignant disease - Peri- and posttherapeutic intravenous high-dose antibiotics until the 5th day postoperative using Unacid 3g i.v. 1-1-1 - Peri- and post-therapeutic diet by means of nasogastric probe food

Exclusion criteria

Exclusion criteria: - positive history of radiation in the head and neck area - MRONJ Diagnosis without Clinical Exposure of Exposed Jaw Bone (Stage 0) - microvascular reconstruction in the head and neck area - Patients with renovations under local anesthesia - Hemorrhagic diathesis or thrombocytopenia <150,000 / µl

Design outcomes

Primary

MeasureTime frame
Clinical success (completed wound healing without bone exposure) at time points t1 (5 days postop), t2 (14 days postop, +/- 1 day) and t3 (6 weeks postop, +/- 3 days)

Secondary

MeasureTime frame
- Clinical downstaging based on the AAOMS (American Association of Oral and Maxillofacial Surgeons) classification - Change of pain sensation - Change in the oral health-related quality of life

Countries

Germany

Contacts

Public ContactS. Dembelé

Klinik für Mund-, Kiefer- und Gesichtschirurgie

simone.dembele@uksh.de0431/500-26000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026